Apollo Endosurgery Inc EBITDA margin
Cos'è EBITDA margin di Apollo Endosurgery Inc?
EBITDA margin di Apollo Endosurgery Inc è -60.86%
Qual è la definizione di EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin di aziende nel Health Care settore su NASDAQ rispetto a Apollo Endosurgery Inc
Cosa fa Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Aziende con ebitda margin simili a Apollo Endosurgery Inc
- Megalith ha EBITDA margin di -61.33%
- Sailfish Royalty ha EBITDA margin di -61.30%
- Echo Plc ha EBITDA margin di -61.25%
- Avita Medical ha EBITDA margin di -61.20%
- Hutchison China MediTech ha EBITDA margin di -61.12%
- Tu Yi ha EBITDA margin di -60.99%
- Apollo Endosurgery Inc ha EBITDA margin di -60.86%
- Aurinia Pharmaceuticals ha EBITDA margin di -60.84%
- Hostelworld plc ha EBITDA margin di -60.83%
- Taal Distributed Information Technologies ha EBITDA margin di -60.81%
- Weimob ha EBITDA margin di -60.69%
- Cluey Ltd ha EBITDA margin di -60.68%
- Waterdrop ha EBITDA margin di -60.59%